| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/25/1995 | CN1097622A 止血散 Hemostatic Powder |
| 01/24/1995 | US5384398 High molecular mass N,O-sulphated heparosans, process for their preparation and the pharmaceutical compositions which contain them |
| 01/24/1995 | CA1334079C Method of producing lys-plasminogen |
| 01/23/1995 | CA2128464A1 Bicyclic heterocyclic compounds, pharmaceutical preparations containing these compounds and processes for their preparation |
| 01/23/1995 | CA2128348A1 Glycoprotein iib/iiia antagonists |
| 01/19/1995 | WO1995002054A2 Platelet glycoprotein v gene and uses |
| 01/19/1995 | WO1995002038A1 Yolk sac stem cells and their uses |
| 01/19/1995 | WO1995001990A1 Hemoregulatory penta- or hexapeptides |
| 01/19/1995 | WO1995001804A1 A coagulation factor viii formulation |
| 01/19/1995 | CA2166872A1 Platelet glycoprotein v gene and uses |
| 01/19/1995 | CA2166694A1 Yolk sac stem cells and their uses |
| 01/18/1995 | EP0633895A1 Oxygen carrier |
| 01/18/1995 | CN1097421A Adhesion receptor antagonists |
| 01/17/1995 | US5382670 Platelet activating factor antagonists |
| 01/17/1995 | US5382593 Antioxidants or anticoagulants |
| 01/17/1995 | US5382577 Pharmaceutical composition for inhibiting platelet aggregation |
| 01/16/1995 | CA2127897A1 Bifunctional variants of urokinase with improved fibrinolytic properties and thrombin-inhibiting activity |
| 01/12/1995 | WO1995001433A1 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods |
| 01/12/1995 | WO1995001427A1 Pro-urokinase mutants |
| 01/12/1995 | WO1995001375A1 Inhibitor of collagen-stimulated platelet aggregation |
| 01/12/1995 | WO1995001373A1 Process for manufacture of 1-deamino-8-d-arginine vasopressin |
| 01/12/1995 | WO1995001372A1 Peptidase resistant thrombin receptor peptide ligand |
| 01/12/1995 | WO1995001343A1 Pyridazinone derivatives with pharmaceutical activity |
| 01/12/1995 | CA2165977A1 Pro-urokinase mutants |
| 01/11/1995 | EP0632829A1 Thrombin receptor antagonists |
| 01/11/1995 | EP0544821B1 Indole derivatives as antiallergy and antiinflammatory agents |
| 01/11/1995 | CN1027370C Process for production of thiazole derivatives |
| 01/10/1995 | US5380824 One-step, one-container method for the preparation of pyridoxylated hemoglobin |
| 01/10/1995 | US5380713 Serine protease inhibitors |
| 01/10/1995 | US5380712 Truncated human serum albumin polypeptides as plasma expanding agents |
| 01/05/1995 | WO1995000844A1 Novel clinical marker and therapeutic agent in kidney stone disease and methods of use |
| 01/05/1995 | WO1995000544A1 Method and composition for treating thrombosis |
| 01/05/1995 | WO1995000541A1 Factor vii-derived peptides |
| 01/05/1995 | WO1995000501A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/05/1995 | WO1995000472A1 1,2 diacylated hydrazine derivatives and their use as all adhesion inhibitors |
| 01/05/1995 | WO1995000152A1 Pharmaceutical composition containing heparin, heparin fragments or their derivatives in combination with glycerol esters |
| 01/05/1995 | CA2364039A1 Use of phenyl heterocycles in the relief or treatment of rheumatoid arthritis, osteoarthritis, fever, pain, headache or dysmenorrhea |
| 01/05/1995 | CA2165332A1 Method and composition for treating thrombosis |
| 01/05/1995 | CA2164422A1 Factor vii-derived peptides |
| 01/05/1995 | CA2163888A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/04/1995 | EP0632020A1 Allophanic acid derivatives |
| 01/04/1995 | EP0632019A1 Acylureas |
| 01/04/1995 | EP0632016A1 1,2-Diacylated hydrazine derivatives and their use as cell adhesion inhibitors |
| 01/04/1995 | EP0631777A1 Use of derivatives of beta-naphthoquinone for inhibiting platelet aggregation |
| 01/04/1995 | EP0631776A1 Use of beta-naphthoquinone for accelerating the proliferation of endothelial cells and inhibiting no synthases |
| 01/04/1995 | EP0631501A1 Glycosylation-mediated inhibition of factor x |
| 01/04/1995 | CN1027268C Method for preparation of new benzopyranone-beta-D-thioxylosides |
| 01/03/1995 | US5378716 Pyrazol-1-yl phenoxyacetic acid compounds which have useful pharmaceutical utility |
| 01/03/1995 | US5378712 Antithrombosis |
| 01/03/1995 | CA1333803C .alpha.-substituted 4-(quinolin-2-yl-methoxy)phenylacetic acids and esters |
| 01/03/1995 | CA1333802C Substituted 4-(quinolin-2-yl-methoxy)phenyl-acetic acid derivatives |
| 12/29/1994 | CA2126038A1 Allophanic acid derivatives |
| 12/29/1994 | CA2126037A1 Chemical compounds |
| 12/28/1994 | EP0630366A1 Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
| 12/28/1994 | EP0630275A1 Fibrin sealant delivery method |
| 12/28/1994 | EP0617705A4 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them. |
| 12/27/1994 | US5376632 Cyclodextrin based erythropoietin formulation |
| 12/27/1994 | US5376631 Oxidation products containing the D-region of fibrinogen with methionine residues which have been oxidized to methionine sulfoxide, as stimulants for plasminogen activators |
| 12/27/1994 | US5376553 Analyzing biological fluid samples for presence of dicitrate cyclic diester which indicates no pathological calcification or predisposition towards it |
| 12/27/1994 | US5376547 With modifications in amino acid content which eliminate binding to liver membranes and aid in maintaining concentration in blood |
| 12/22/1994 | WO1994029471A1 Adenoviral vectors for treatment of hemophilia |
| 12/22/1994 | WO1994029349A1 Trifunctional antithrombin and antiplatelet peptides |
| 12/22/1994 | WO1994029341A1 Methods of enhancing bioactivity of chemokines |
| 12/22/1994 | WO1994029336A1 New peptide derivatives |
| 12/22/1994 | WO1994029280A1 Pyrimidine cyanoguanidines as k-channel blockers |
| 12/22/1994 | WO1994029273A1 Bicyclic fibrinogen antagonists |
| 12/22/1994 | WO1994028950A1 Plasma-like solution |
| 12/22/1994 | WO1994025588A3 ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-β (TGF-β) |
| 12/22/1994 | WO1994022835A3 Heterocyclic compounds as platelet aggregation inhibitors |
| 12/22/1994 | WO1994017773A3 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 12/22/1994 | CA2162497A1 Adenoviral vectors for treatment of hemophilia |
| 12/22/1994 | CA2161325A1 Pyrimidine, cyanoguandines as k-channel blockers |
| 12/21/1994 | EP0629407A2 Use of human protein C for prevention and treatment of depositions of thrombocytes |
| 12/21/1994 | EP0629211A1 4-oxo-2 thioxoimidazolidine derivates as inhibitors of blood platelet aggregation |
| 12/21/1994 | CN1027068C Alpha-substituted 4-(quinolin-2-yl-methoxy)-phenylacetic acide and-esters |
| 12/20/1994 | US5374660 Asministering a benzoic hydrazide to treat antigrowth of fibroblasts, fibronectins, collagen |
| 12/20/1994 | US5374647 Antithrombotic substituted cycloalkano (B) dihydroindole sulphonamides |
| 12/20/1994 | US5374640 Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides |
| 12/20/1994 | US5374622 Fibrinogen receptor antagonists |
| 12/20/1994 | CA1333603C Sulfamoyl-2-benzofurancarboxylic acid derivative |
| 12/20/1994 | CA1333569C Method of treatment for autoimmune diseases |
| 12/14/1994 | EP0628571A1 Novel peptide, and antithrombotic agent, anticoagulant for extracorporeal circulation, cell fusion inhibitor, cancer metastasis inhibitor, protective for platelet preparation for transfusion and pack of platelet preparation for transfusion |
| 12/14/1994 | EP0627929A1 Inhibitors of thrombosis |
| 12/14/1994 | EP0627923A1 Therapeutic domains of von willebrand factor |
| 12/14/1994 | EP0627918A1 New use of omega-3-fatty acids |
| 12/14/1994 | EP0627913A1 Facilitated oxygen delivery in conjunction with hemodilution |
| 12/13/1994 | US5373019 Pharmaceutical lactam compositions for inhibition of erythrocyte and thrombocyte aggregation |
| 12/13/1994 | US5372933 Antibody-polypeptide immunocomplex |
| 12/13/1994 | US5372808 Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
| 12/08/1994 | WO1994028391A1 Ligands for flt3 receptors |
| 12/08/1994 | WO1994028151A1 Gene therapy for haemophilia |
| 12/08/1994 | WO1994028145A2 Expression of urokinase plasminogen activator inhibitors |
| 12/08/1994 | WO1994028137A1 Regulator of contact-mediated hemolysin |
| 12/08/1994 | WO1994028013A1 Peptides for suppression of myeloid progenitor cell proliferation and treatment of septic shock |
| 12/08/1994 | WO1994027632A1 Cell growth regulators |
| 12/08/1994 | WO1994027631A1 Modified factor vii |
| 12/08/1994 | WO1994027627A1 Hemoregulatory peptides |
| 12/08/1994 | WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 12/08/1994 | DE4403057C1 Platelet-stabilising factor IX fragments, the preparation thereof and pharmaceutical compositions containing them |
| 12/08/1994 | CA2163438A1 Regulator of contact-mediated hemolysin |